The American Society of Clinical Oncology (ASCO) recently published a special article in the Journal of Clinical Oncology that idicated that even one alcoholic drink per day can increase cancer risk.
Heavy, long-term alcohol consumption is known to be one of the many risk factors associated with developing cancer. But, does having 1 alcoholic drink a day increase your chances of developing the disease, too?
The Cancer Prevention Committee of the American Society of Clinical Oncology (ASCO) recently published a special article in the Journal of Clinical Oncology on alcohol consumption and cancer risk.
The article reflects ASCO’s position that while the greatest risks of developing various cancers are associated with heavy, long-term alcohol consumption, even low alcohol consumption (defined as less than 1 drink per day) or moderate consumption (up to 2 drinks per day for men, and 1 drink per day for women) can increase the risk of cancer.
How alcohol affects disease treatment outcomes is unknown. ASCO plans to include research on consuming alcohol during cancer treatment in its research agenda.
In addition, ASCO plans to provide leadership in the cancer community on this issue, including public education on the risks between alcohol abuse and certain types of cancer, as well as the need for evidence-based strategies that prevent excessive consumption of alcohol.
FDA Approves T-DXd for Previously Treated HER2-Low and -Ultralow Metastatic Breast Cancer
Published: January 27th 2025 | Updated: January 28th 2025T-DXd has received FDA approval for the treatment of unresectable or metastatic HR+, HER2-low/-ultralow breast cancer in patients whose disease progressed on prior endocrine therapy in the metastatic setting.
ctDNA Status May Be Prognostic for DFS With Celecoxib for Stage III Resected Colon Cancer
January 26th 2025While ctDNA positivity was linked to worse overall disease-free survival (DFS) in stage III resected colon cancer, it was associated with significantly improved DFS with celecoxib compared to placebo.